A seasoned executive with one of the world’s top medical device companies, over the last 15 years Audrey Beckham has served in several executive roles with Zimmer Biomet. After beginning her career as an engineer in product development in 1987, she held global leadership roles in product development, upstream marketing, medical training and education, and strategic quality initiatives. Excelling in leadership of technical and non-technical teams throughout her tenure, Audrey led international teams of engineers, scientists, marketing staff, and orthopedic surgeons. She was recognized for her skill at developing and executing complex strategies and initiatives.
During her early career, Audrey developed and commercialized numerous knee implant and instrumentation systems, leading internal technical and international surgical teams in parallel with hands-on design activities. After helping develop and commercialize the worlds’ best-selling knee implant system, Audrey began her management career in 1996, assuming leadership of Zimmer’s Knee Development Engineering team. Her leadership path continued through numerous restructurings and integrations to vice president, Global Product Development, with an international team of more than 350 technical staff, including project office, prototype shop and packaging design. Recognized for leadership, portfolio management and product development process, she gained P&L experience as leader of Zimmer’s largest global business unit in its initial years as a publicly traded company. She also participated in corporate strategic and financial planning sessions for more than 15 years, during which Zimmer developed and executed the industry’s leading minimally invasive surgery strategy for total hip and total knee replacement.
Medical Devices is a regulated industry with FDA, EU, and individual country regulations governing all processes related to products from idea through implantation in patients for the lifetime of the device. The orthopedic industry went through a period of significant change relative to relationships with surgeons who are both customers and consultants. Audrey was an essential leader of the Zimmer R&D team as it developed new methods of valuing intellectual property, compensation of consultants and documenting the needs for consulting activities for internal approval and external oversight. She rebuilt and led the Global Medical Education and Training team, improving educational effectiveness as well as ensuring transparency and compliance with U.S. and international law, in alignment with AdvaMed and Eucomed guidelines. The team grew from 30 to 100 people in more than 20 countries, with an annual budget exceeding $70 million and training 28,000 health care professionals. Audrey also negotiated and collaborated with industry associations to develop and implement new grant and donation practices for the healthcare professional education and support of needy patients worldwide.
Her last role with Zimmer and Zimmer Biomet Holdings, Inc., was to lead a 1,300-person technical team to update and remediate quality system documentation for historical products developed or manufactured at four sites. In this role, she reported to the CEO, made quarterly presentations to the board of directors and submitted quarterly updates to the FDA. Audrey was one of three executives on the steering committee for the initiative and the only executive to stay with the initiative for two-plus years.
Audrey has been active in the Warsaw, Indiana, community and with her alma mater, the University of Notre Dame where she earned a Bachelor of Science in mechanical engineering in 1987. he also earned an MBA from Ball State University. She is an active participant on the University of Notre Dame’s Department of Aerospace and Mechanical Engineering Industry Advisory Board, the College of Engineering Advisory Council to the President, and the Women in Engineering Advisory Council. She was instrumental in helping the College of Engineering receive multi-year research grants for pioneering research related to a new medical device technology.
Audrey is an angel investor with VisionTech Partners, focusing her investments on start-up medical device companies. She also advises on pitch decks, business opportunities and scaling. companies She is the first independent board member for Board Management Software, Inc., which primarily serves non-profit organizations. She serves on the board of directors for a non-profit, Court Appointed Special Advocates of Kosciusko County, chairing the governance committee after serving as president for a two-year term.